• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型中枢神经系统药物传递系统。

Novel central nervous system drug delivery systems.

机构信息

Department of Physiology, 2D01 Health Sciences, 107 Wiggins Rd., Saskatoon, SK, S7N 5E5, Canada; Department of Pharmacology, 2D01 Health Sciences, 107 Wiggins Rd., Saskatoon, SK, S7N 5E5, Canada.

出版信息

Chem Biol Drug Des. 2014 May;83(5):507-20. doi: 10.1111/cbdd.12268. Epub 2014 Mar 14.

DOI:10.1111/cbdd.12268
PMID:24325540
Abstract

For decades, biomedical and pharmaceutical researchers have worked to devise new and more effective therapeutics to treat diseases affecting the central nervous system. The blood-brain barrier effectively protects the brain, but poses a profound challenge to drug delivery across this barrier. Many traditional drugs cannot cross the blood-brain barrier in appreciable concentrations, with less than 1% of most drugs reaching the central nervous system, leading to a lack of available treatments for many central nervous system diseases, such as stroke, neurodegenerative disorders, and brain tumors. Due to the ineffective nature of most treatments for central nervous system disorders, the development of novel drug delivery systems is an area of great interest and active research. Multiple novel strategies show promise for effective central nervous system drug delivery, giving potential for more effective and safer therapies in the future. This review outlines several novel drug delivery techniques, including intranasal drug delivery, nanoparticles, drug modifications, convection-enhanced infusion, and ultrasound-mediated drug delivery. It also assesses possible clinical applications, limitations, and examples of current clinical and preclinical research for each of these drug delivery approaches. Improved central nervous system drug delivery is extremely important and will allow for improved treatment of central nervous system diseases, causing improved therapies for those who are affected by central nervous system diseases.

摘要

几十年来,生物医学和制药研究人员一直致力于设计新的、更有效的疗法来治疗影响中枢神经系统的疾病。血脑屏障有效地保护了大脑,但这对跨越这一屏障的药物输送构成了巨大的挑战。许多传统药物不能以可观的浓度穿过血脑屏障,大多数药物中只有不到 1%到达中枢神经系统,导致许多中枢神经系统疾病(如中风、神经退行性疾病和脑肿瘤)缺乏可用的治疗方法。由于大多数中枢神经系统疾病的治疗效果不佳,因此开发新型药物输送系统是一个非常关注和积极研究的领域。多种新型策略显示出有效传递中枢神经系统药物的潜力,为未来提供更有效和更安全的治疗方法。这篇综述概述了几种新型药物输送技术,包括鼻内药物输送、纳米颗粒、药物修饰、对流增强输注和超声介导药物输送。它还评估了这些药物输送方法中的每一种的可能的临床应用、局限性和当前临床前和临床研究的例子。改善中枢神经系统药物输送非常重要,它将使中枢神经系统疾病的治疗得到改善,从而为受中枢神经系统疾病影响的患者提供更好的治疗方法。

相似文献

1
Novel central nervous system drug delivery systems.新型中枢神经系统药物传递系统。
Chem Biol Drug Des. 2014 May;83(5):507-20. doi: 10.1111/cbdd.12268. Epub 2014 Mar 14.
2
Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier.用于克服血脑屏障的新型和新兴药物传递策略。
Future Med Chem. 2009 Dec;1(9):1623-41. doi: 10.4155/fmc.09.137.
3
Peptides: important tools for the treatment of central nervous system disorders.肽类药物:中枢神经系统疾病治疗的重要工具。
Neuropeptides. 2011 Oct;45(5):309-16. doi: 10.1016/j.npep.2011.03.001. Epub 2011 Apr 7.
4
Nanobiotechnology-based drug delivery to the central nervous system.基于纳米生物技术的中枢神经系统药物递送
Neurodegener Dis. 2007;4(4):287-91. doi: 10.1159/000101884.
5
Drug delivery to the central nervous system: a review.药物向中枢神经系统的递送:综述
J Pharm Pharm Sci. 2003 May-Aug;6(2):252-73.
6
Strategies for drug delivery to the central nervous system by systemic route.通过全身途径向中枢神经系统给药的策略。
Drug Deliv. 2015 May;22(3):243-57. doi: 10.3109/10717544.2013.878858. Epub 2014 Jan 29.
7
Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.用于将药物递送至中枢神经系统的血脑屏障的概念、技术和实践。
J Control Release. 2016 Oct 28;240:251-266. doi: 10.1016/j.jconrel.2015.12.041. Epub 2015 Dec 24.
8
Prodrug approaches to reduce hyperexcitation in the CNS.前药策略降低中枢神经系统过度兴奋。
Adv Drug Deliv Rev. 2012 May 15;64(7):666-85. doi: 10.1016/j.addr.2011.11.007. Epub 2011 Nov 27.
9
Strategies for transporting nanoparticles across the blood-brain barrier.跨越血脑屏障的纳米颗粒转运策略。
Biomater Sci. 2016 Feb;4(2):219-29. doi: 10.1039/c5bm00383k.
10
Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.代谢型谷氨酸受体配体通过载体介导向中枢神经系统的递送:血脑屏障处L-系统氨基酸转运体的结构耐受性及潜力
J Cereb Blood Flow Metab. 2000 Jan;20(1):168-74. doi: 10.1097/00004647-200001000-00021.

引用本文的文献

1
Response of Serum-Isolated Extracellular Vesicles to Focused Ultrasound-Mediated Blood-Brain Barrier Opening.血清分离的细胞外囊泡对聚焦超声介导的血脑屏障开放的反应。
Ultrasound Med Biol. 2025 May 30. doi: 10.1016/j.ultrasmedbio.2025.04.019.
2
Harnessing the Potential of Exosomes in Therapeutic Interventions for Brain Disorders.利用外泌体在脑部疾病治疗干预中的潜力。
Int J Mol Sci. 2025 Mar 11;26(6):2491. doi: 10.3390/ijms26062491.
3
Revolutionizing Parkinson's treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy.
变革帕金森病治疗:利用鼻内纳米乳剂进行靶向治疗的潜力。
Drug Deliv Transl Res. 2025 Jan 8. doi: 10.1007/s13346-024-01770-z.
4
Technological Strategies Applied to Pharmaceutical Systems for Intranasal Administration of Drugs Intended for Neurological Treatments: A Review.技术策略在用于治疗神经系统疾病的药物经鼻腔给药的药物传递系统中的应用:综述。
AAPS PharmSciTech. 2024 Nov 1;25(8):258. doi: 10.1208/s12249-024-02974-9.
5
Neuroprotective Role of Phytoconstituents-based Nanoemulsion for the Treatment of Alzheimer's Disease.基于植物成分的纳米乳在治疗老年痴呆症中的神经保护作用。
Curr Top Med Chem. 2024;24(19):1683-1698. doi: 10.2174/0115680266296001240327090111.
6
Exosomes as a potential therapeutic approach in osteoimmunology.外泌体在骨免疫学中的潜在治疗方法。
Front Immunol. 2023 Dec 19;14:1309015. doi: 10.3389/fimmu.2023.1309015. eCollection 2023.
7
Characterization of the responses of brain macrophages to focused ultrasound-mediated blood-brain barrier opening.脑内巨噬细胞对聚焦超声介导的血脑屏障开放反应的特征。
Nat Biomed Eng. 2024 May;8(5):650-663. doi: 10.1038/s41551-023-01107-0. Epub 2023 Oct 19.
8
Caffeic acid recarbonization: A green chemistry, sustainable carbon nano material platform to intervene in neurodegeneration induced by emerging contaminants.没食子酸碳化:一种绿色化学、可持续碳纳米材料平台,可干预新兴污染物诱导的神经退行性变。
Environ Res. 2023 Nov 15;237(Pt 1):116932. doi: 10.1016/j.envres.2023.116932. Epub 2023 Aug 19.
9
Targeted drug delivery to the brain endothelium dominates over passive delivery via vascular leak in experimental intracerebral hemorrhage.靶向递送至脑内皮细胞在实验性脑出血中比通过血管渗漏的被动递送达更占优势。
J Control Release. 2023 Apr;356:185-195. doi: 10.1016/j.jconrel.2023.02.037. Epub 2023 Mar 7.
10
Microbubble Delivery Platform for Ultrasound-Mediated Therapy in Brain Cancers.用于脑癌超声介导治疗的微泡递送平台
Pharmaceutics. 2023 Feb 19;15(2):698. doi: 10.3390/pharmaceutics15020698.